Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 266.50
-1.80 (-0.67%)
Sep 10, 2026, 5:24 PM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 80.79 million as of September 11, 2026. Its market cap has decreased by -33.64% in one year.
Market Cap
80.79M
Enterprise Value
70.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
266.50
ChartMarket Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 80.79M, an increase of 30.31%. That is a compound annual growth rate of 5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 80.79M | -46.83% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 202.09M |
| Clal Biotechnology Industries | 40.31M |
| BioLineRx | 34.07M |
| BioLight Life Sciences | 26.35M |
| XTL Biopharmaceuticals | 25.16M |
| Evogene | 23.78M |
| Purple Biotech | 18.65M |
| Can-Fite BioPharma | 14.84M |